by Impulse Dynamics | Jan 20, 2021 | News and Events, Press Releases
NEWS IMPULSE DYNAMICS ANNOUNCES FDA APPROVAL FOR MAGNETICRESONANCE IMAGING FDA Clears Potential Hurdle for Many Heart Failure Patients MARLTON, N.J., January 20, 2021 — Impulse Dynamics, a company dedicated to improving the lives of people with heart failure (HF),...
by Impulse Dynamics | Jan 12, 2021 | News and Events, Press Releases
NEWS IMPULSE DYNAMICS CLOSES $60 MILLION FINANCING Funding to Accelerate Clinical and Product Development Pipelines, Commercialization of Optimizer Smart System for Heart Failure MARLTON, N.J., January 12, 2021 — Impulse Dynamics, a company dedicated to helping...
by Impulse Dynamics | Jan 5, 2021 | Press Releases
NEWS Impulse Dynamics Announces First Heart Failure Patient Treated with CCM Therapy in Brazil Breakthrough Therapy Now Commercially Available in South America’s Most Populous Country MARLTON, N.J. – January 05, 2021 – Impulse Dynamics, a company dedicated to helping...
by Impulse Dynamics | Apr 14, 2020 | Press Releases
NEWS Impulse Dynamics Announces Publication of Data from FIX-HF-5C2 Study Evaluating the Two-Lead Optimizer System Availability of the two-lead device represents a significant advancement in the development of cardiac contractility modulation therapy for patients with...
by Impulse Dynamics | Mar 17, 2020 | Press Releases
NEWS Impulse Dynamics Announces First Enrollment in Post-Approval Study of CCM Therapy Delivered by the Optimizer System Post-Approval Study will evaluate real-world safety and efficacy evidence for breakthrough heart failure therapy MOUNT LAUREL, N.J. – March 17,...
Recent Comments